Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 673,805 | 727,566 | 793,361 | 756,564 | 750,342 |
| Marketable Securities | 460 | 739 | 703 | 763 | N/A |
| Receivables | 391,293 | 373,091 | 331,096 | 297,614 | 314,114 |
| Inventories | 31,929 | 31,264 | 30,424 | 32,415 | 34,594 |
| Other current assets | 238,924 | 198,266 | 180,804 | 204,381 | 230,352 |
| TOTAL | $1,414,709 | $1,408,062 | $1,388,261 | $1,338,119 | $1,389,280 |
| Non-Current Assets | |||||
| PPE Net | 461,841 | 466,720 | 470,608 | 478,481 | 472,663 |
| Investments And Advances | 81,220 | 85,022 | 80,205 | 78,017 | 73,757 |
| Intangibles | 919,378 | 894,320 | 926,957 | 936,973 | 937,083 |
| Other Non-Current Assets | 372,346 | 337,999 | 361,729 | 364,411 | 356,253 |
| TOTAL | $1,834,785 | $1,784,061 | $1,839,499 | $1,857,882 | $1,839,756 |
| Total Assets | $3,249,494 | $3,192,123 | $3,227,760 | $3,196,001 | $3,229,036 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,688 | 8,668 | 17,840 | 17,234 | 17,288 |
| Accrued Expenses | 405,200 | 376,212 | 369,256 | 317,422 | 376,498 |
| Other current liabilities | 38,837 | 37,094 | 31,382 | 36,031 | 39,615 |
| TOTAL | $474,606 | $443,507 | $437,790 | $388,785 | $457,485 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 147,217 | 145,391 | 157,702 | 192,494 | 188,099 |
| TOTAL | $147,756 | $145,745 | $158,024 | $192,965 | $188,532 |
| Total Liabilities | $622,362 | $589,252 | $595,814 | $581,750 | $646,017 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,598 | 95,540 | 95,506 | 95,844 | 96,066 |
| Common Shares | 93 | 94 | 94 | 94 | 95 |
| Retained earnings | 2,630,175 | 2,604,358 | 2,634,980 | 2,618,163 | 2,601,552 |
| Other shareholders' equity | -3,136 | -1,581 | -3,128 | -4,006 | -18,628 |
| TOTAL | $2,627,132 | $2,602,871 | $2,631,946 | $2,614,251 | $2,583,019 |
| Total Liabilities And Equity | $3,249,494 | $3,192,123 | $3,227,760 | $3,196,001 | $3,229,036 |